TG THERAPEUTICS, INC. (TGTX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US88322Q1085
TG THERAPEUTICS, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 616.29 m USD |
| Gross profit | 515.57 m USD |
| Operating income | 123.32 m USD |
| EBIT | 134.12 m USD |
| Net income | 447.18 m USD |
| Diluted EPS – continuing operations | 2.77 USD |
Full history since 1996, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About TG THERAPEUTICS, INC.
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Ublituximab IV, glycoengineered anti-CD20 mAb for the treatment of relapsing MS; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Jiangsu Hengrui Medicine Co. The company was incorporated in 1993 and is based in Morrisville, North Carolina.
More stocks
- Edenred SE (EDEN.PA)
- Hulic Co Ltd (3003.T)
- Central Pattana Public Company Limited (CPN.BK)
- The Lottery Corporation Ltd (TLC.AX)
- Ecopro BM. Co. Ltd (247540.KQ)
- Empire Company Ltd (EMP.A.TO)
- UGI CORP /PA/ (UGI)
- InterDigital, Inc. (IDCC)
- VIAVI SOLUTIONS INC. (VIAV)
- Korea Aerospace Industries (047810.KS)
- Axsome Therapeutics, Inc. (AXSM)
- FORMFACTOR INC (FORM)
Not investment advice. All data without warranty, price as of 16.10.2026. Details in the risk notice.